Our intern, Emi Miyashita (CiRA, Kyoto Univ.), developed a new method for detecting specific RNA structures and presented the research results at the 50th International Symposium on Nucleic Acids Chemistry (ISNAC2023). This research received the Outstanding Poster Award.
Title: BIVID-MaP identifies allele-specific interaction between small-molecule and RNA structure
Click here for more information
About xFOREST Therapeutics
xFOREST Therapeutics Co., Ltd. is a Kyoto-based biotechnology company engaged in the research and development of RNA-targeted small-molecule medicines. Building on its proprietary RNA structure analysis technology, xFOREST discovers selective small molecules for RNA targets that protein-first discovery cannot reach, and advances them into drug programs with partners.